Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Curley Joanne Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 1,490 shares @ $16.6558, valued at $24.8k
12/19/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 1,429 shares @ $19.1204, valued at $27.3k
Sold 783 shares @ $20.1697, valued at $15.8k
Exercised 2,212 options to buy @ $2.8968, valued at $6.4k
12/14/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 6,900 shares @ $18.2498, valued at $125.9k
Sold 11,733 shares @ $18.2767, valued at $214.4k
Sold 1,078 shares @ $18.19, valued at $19.6k
Exercised 6,900 options to buy @ $11, valued at $75.9k
Exercised 11,733 options to buy @ $11, valued at $129.1k
Exercised 1,078 options to buy @ $6.3728, valued at $6.9k
12/08/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 494 shares @ $16.47, valued at $8.1k
11/21/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 1,078 shares @ $15.8606, valued at $17.1k
Sold 2,211 shares @ $15.8436, valued at $35k
Exercised 1,078 options to buy @ $6.3728, valued at $6.9k
Exercised 2,211 options to buy @ $2.8968, valued at $6.4k
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 988 shares @ $21.64, valued at $21.4k
09/22/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 978 shares @ $20.5442, valued at $20.1k
Sold 100 shares @ $21, valued at $2.1k
Sold 1,828 shares @ $20.4757, valued at $37.4k
Sold 334 shares @ $20.9153, valued at $7k
Sold 2,314 shares @ $20.241, valued at $46.8k
Sold 10,112 shares @ $20.8045, valued at $210.4k
Sold 910 shares @ $21.1255, valued at $19.2k
Sold 264 shares @ $22.3465, valued at $5.9k
Exercised 1,078 options to buy @ $6.3728, valued at $6.9k
Exercised 2,162 options to buy @ $2.8968, valued at $6.3k
Exercised 12,426 options to buy @ $11, valued at $136.7k
09/08/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 988 shares @ $18.63, valued at $18.4k
08/23/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 12,500 shares @ $0
Sold 378 shares @ $18.8854, valued at $7.1k
Sold 700 shares @ $19.7607, valued at $13.8k
Sold 710 shares @ $18.9312, valued at $13.4k
Sold 1,451 shares @ $19.8685, valued at $28.8k
Sold 2,766 shares @ $18.6114, valued at $51.5k
Sold 904 shares @ $19.8055, valued at $17.9k
Sold 1,030 shares @ $18.4241, valued at $19k
Sold 600 shares @ $19.6457, valued at $11.8k
Exercised 1,078 options to buy @ $6.3728, valued at $6.9k
Exercised 2,161 options to buy @ $2.8968, valued at $6.3k
08/04/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 988 shares @ $16.81, valued at $16.6k
07/20/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 5,384 shares @ $16.0158, valued at $86.2k
Sold 6 shares @ $16.55, valued at $99.3
Sold 6,046 shares @ $16.0123, valued at $96.8k
Sold 8 shares @ $16.545, valued at $132.4
Exercised 5,390 options to buy @ $6.3728, valued at $34.3k
Exercised 6,054 options to buy @ $2.8968, valued at $17.5k
07/15/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 6,354 shares @ $15.1297, valued at $96.1k
Sold 2,750 shares @ $15.1744, valued at $41.7k
Exercised 6,354 options to buy @ $2.8968, valued at $18.4k
07/11/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Sold 3,487 shares @ $15.0332, valued at $52.4k
Sold 3,514 shares @ $15.0764, valued at $53k
Sold 2,665 shares @ $15.0297, valued at $40.1k
Exercised 3,487 options to buy @ $6.3728, valued at $22.2k
Exercised 3,514 options to buy @ $2.8968, valued at $10.2k
06/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2022 4 Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns: Granted 52,964 options to buy @ $20.94, valued at $1.1M
05/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/13/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
04/27/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2021 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy